The primary objective is to establish the number of patients randomised as a proportion of those eligible to enter the study. Secondary objectives include evaluation of study processes (patient identification and screening processes, failure to recruit, willingness of clinicians to recruit, randomisation process, blinding, data collection and patient follow-up). The size of this study will not allow reliable assessment of the effect of the TEB and PVB on outcomes.